Search This Blog

Wednesday, November 30, 2016

Motilal Oswal Share Price Zooms 7 Per Cent


Motilal OswalMotilal Oswal share price shot up by more than 7 per cent on the NSE today. It was only yesterday that the stock saw a spurt in Volume by more than 8.28 times. The stock opened at Rs. 501.00 from a previous closing of Rs. 503.80. The day’s high of the stock reads at Rs. 548.25 on the other hand, the day’s low of the stock stood at Rs. 499.10.
Motilal Oswal share price closed at Rs 537.20 apiece on the counter of NSE, up by 7.98 per cent.

The Highs and Lows of Store One share price:

52 Week High (Rs.)640.00 (26-Oct-16)
52 Week Low (Rs.)255.00 (12-Feb-16)
Life Time high (Rs.)640.00 (26-Oct-16)
Life Time low (Rs.)43.60 (05-Mar-09)
 

Motilal Oswal belongs to the financial sector. Its face value stands at Rs.1Out of Top 500 Shares, MOTILAL OSWAL is one of the Multibagger Shares, identified by Dynamic research at the end of every month. MOTILAL OSWAL can be a great investment opportunity which can give you high return. MOTILAL OSWAL is a well analysed multibagger stock, based on our technical and fundamental research, traded in very high volumes. These companies have been seen to multiply their earnings per share every year. These shares have a great potential to grow in the long run.

Its P.E. Ratios are as follows:

Standalone FY 15-16 PE Ratio154.66
Standalone Trailing PE Ratio74.74
Consolidated FY 15-16 PE Ratio42.76



Other Important Fundamentals:

Book Value100.13
Market Cap7229.87 (Cr)
Average Daily Movement [ADM]26.75
Average Volume [20 days]101713
1 Month Return (%)-12.62
 

To seek information on the resistance and support levels of the scrip and know more about its fundamentals and financials, please pay a visit to  Motilal Oswal share price history.

Pharma Sector on a Turnaround, Shows Signs of Booming

Pharma SectorIn March 2009, the Pharma Index was trading at 2020. For the next 6 years until March 2015, Pharma had a continued rally to make a high of 14,020. Thereafter in March 2016, the Pharma Index witnessed highest correction in 7 years to make a low of 10,353. Currently it stands at 11,100.
The Pharma Sector has been all-time performer. However, the recent USFDA inspections have caused a few hiccups leading to correction. As most Pharma companies export in bulk and Rupee is currently at its all-time low (Dollar appreciation against Rupee), the Pharma sector has witnessed buying and profitability.

Rise in share price of Major Pharma Companies Post Budget (since Feb 2016):


StocksCurrent Share Price (in Rs.)Rise in Share Price (%)
598.55
237.12
502
141.06
711.9
133.26
149.1
109.26
596.3
108.31
100
104.29
925.05
97.03
368
95.91
1009
92.72
715.5
85.8
1673.7
84.31
225
80.14
664.9
67.29
239.15
60.67
998
52.77
559.4
47.91
580.3
46.73
607.3
46
350.25
44.64
21.75
43.09
1862
43.01
1180
42.74
637.5
38.03
1715
35.61
266.9
34.73
197
34.52
48
27.83
124.25
27.83
44
26.26
396.4
26
97
25.08
1098
24.84
1169.75
23.06
316
22.41
216.35
20.13
878.3
19.39
50
18.91
102.3
18.27
180.75
18.1
7.35
17.6
98
17.08
38.5
16.31
741.65
13.12
1420.45
12.64
4.3
11.69
6
11.11
570
10.86
6.7
10.74
29.3
7.13
179
6.96
22.4
6.67
38.1
6.57
157.4
6.21
3206
5.59
34.8
5.14
649.15
5.03
35.65
3.94
901.2
3.34
109.15
2.73
4391.2
1.7
39.55
1.41
572.35
1.35
4846.05
1.25
4.65
1.09

The Indian pharmaceutical sector has the potential to grow and increase to the size of 300 billion dollars by the year 2030 from the current 15 billion dollars provided it accords high priority on quality and R&D – research & development, chief executives of top pharmaceutical companies stated.
They said that the Indian firms must foster innovation and develop products for the benefit of the patients adding that companies must address quality compliance challenges and inculcate quality culture in the organisations to develop high quality medicines for all the markets.

Conclusion:

The Pharma Sector is showing a turnaround and many Pharma stocks are hitting 52 week highs. It was only today that Syngene share price touched 52 week high. This is creating an opportunity for other Pharma stocks to do well since the entire sector is performing well. It is an excellent time for Pharma stock lovers to invest. Dynamic Levels Research Analysts have recommended the following multibagger Pharma stocks which can be great for investment:
  • Jubilant
  • Syngene
  • Hikal
  • Neuland Lab
  • RPG Life
  • Piramal Enterprises
  • Lincoln Pharma